“…Common management approaches for treating a verruca can either be destructive (cantharidin, citric acid, cryotherapy, electrosurgery, formic acid, glycolic acid, laser surgery, monochloroacetic acid, phenol, pyruvic acid, salicylic acid, silver nitrate, surgical excision, trichloroacetic acid, and zinc oxide), immune modulating (interferon, intralesional candida antigen, Th-1 (T helper type 1) stimulating vaccination, and topical imiquimod), antiproliferative (bleomycin, 5-fluorouracil, podophyllin, podophyllotoxin, and vitamin D analogues), or antiviral (cidofovir and retinoids). Researchers have also suggested to consider evaluating a patient for immunodeficiency if they have recalcitrant warts, despite treatment with two or more modalities, that persist for more than 18 months [ 1 , 2 ]. In addition, it might be reasonable to consider a biopsy of the clinically suspected verruca in a patient whose lesion is chronic and/or fails to respond to therapy.…”